To study the impact of wearing a Oronasal Surgical mask on 6-min walk distances (6MWDs).
In this study, the patients underwent a submaximal test
i.e. the 6 min-walk test (6MWT) wearing a surgical mask in outpatient care during COVID-19 times and found
that the use of masked 6MWT may serve as a valid clinical assessment tool of
functional exercise capacity.
To study the impact of wearing a Oronasal Surgical mask
on 6-min walk distances (6MWDs).
The 6MWDs of 64 patients with stage-4 lung diseases using an
oronasal surgical mask were compared to earlier examined 6MWDs of the same
group without a mask, before COVID-19. Twenty-nine patients were excluded
because of clinically unstable pulmonary functions, 4 due to a vascular
disease, and 1 due to a menal illness.
Mean age of the included patients was 55 years and 15 of
them were males. Ten patients (32.2%) were on the Eurotransplant lung
transplant wait list with a median lung allocation scores (LAS) of 34.3. Twenty
(64.5%) patients had chronic inflammatory lung illness, 7 (22.6%) had
interstitial lung illnesses, and 4 (12.9%) had other stage-4 lung diseases.
Mean 6MWD with no mask as compared to with a mask
was 306.9 (101.9) and 305.7 (103.8) m.
The use of facial surgical mask did not affect the 6MWDs of
patients with end stage lung diseases.
Respiration
Validity of the 6-Minute Walk Test in Patients with End-Stage Lung Diseases Wearing an Oronasal Surgical Mask in Times of the COVID-19 Pandemic
Isabell Anna Just et al.
Comments (0)